CellMed 2023; 13(5): 4.1-4.3
Published online April 28, 2023
https://doi.org/10.5667/CellMed.spc.020
© Cellmed Orthocellular Medicine and Pharmaceutical Association
Correspondence to : *Young-ro Kim
E-mail: kyr9214@naver.com
Objective: A case report on the improvement of patients with hematologic malignancies by Ortho-Cellular Nutrition Therapy (OCNT).
Methods: A 69-year-old Korean female diagnosed with Stage 4 ACUTE LYMPHOBLASTIC Leukemia (ALL) had a very low platelet count of 8000/μl.
Results: The platelet count improved to its normal level after Ortho-Cellular Nutrition Therapy (OCNT).
Conclusion: Ortho-Cellular Nutrition Therapy (OCNT) is effective in relieving the symptoms of acute lymphoblastic leukemia patients with thrombocytopenia.
Keywords Ortho-Cellular Nutrition Therapy (OCNT), ACUTE LYMPHOBLASTIC Leukemia (ALL), and Platelet
CellMed 2023; 13(5): 4.1-4.3
Published online April 28, 2023 https://doi.org/10.5667/CellMed.spc.020
Copyright © Cellmed Orthocellular Medicine and Pharmaceutical Association.
Pharmacist, Young-ro Kim
Jayeonjuui Pharmacy, 1F, 90, Dasan-ro, Jung-gu, Seoul, Republic of Korea
Correspondence to:*Young-ro Kim
E-mail: kyr9214@naver.com
Objective: A case report on the improvement of patients with hematologic malignancies by Ortho-Cellular Nutrition Therapy (OCNT).
Methods: A 69-year-old Korean female diagnosed with Stage 4 ACUTE LYMPHOBLASTIC Leukemia (ALL) had a very low platelet count of 8000/μl.
Results: The platelet count improved to its normal level after Ortho-Cellular Nutrition Therapy (OCNT).
Conclusion: Ortho-Cellular Nutrition Therapy (OCNT) is effective in relieving the symptoms of acute lymphoblastic leukemia patients with thrombocytopenia.
Keywords: Ortho-Cellular Nutrition Therapy (OCNT), ACUTE LYMPHOBLASTIC Leukemia (ALL), and Platelet
Pharmacist, Young Mi Ha
CellMed 2024; 14(11): 4.1-4.3Pharmacist, Jong-Bin Jo
CellMed 2024; 14(11): 3.1-3.4Pharmacist, Minho Baek
CellMed 2024; 14(11): 2.1-2.4